Ad
related to: etx
Search results
e-therapeutics plc (LON:ETX) insiders have significant skin in the game with 54% ownership
Simply Wall St. via Yahoo Finance· 2 years agoTo get a sense of who is truly in control of e-therapeutics plc (LON:ETX), it is important to...
Eliem Therapeutics Outlines Interim Data From Early-Stage Depressive Study
Benzinga via Yahoo Finance· 2 years agoEliem Therapeutics Inc (NASDAQ: ELYM) announced interim results from its ongoing Phase 1 trial of...
JOB ALERT: UT Health ETX Physicians in Whitehouse needs a Nurse Practitioner
KETK Tyler via Yahoo News· 2 months agoUT Health ETX Physicians Whitehouse, TX Nurse Practitioner About UT Health East Texas:UT Health East...
Eliem Therapeutics Shares Fall On Lower Back Pain Trial Setback
Benzinga via Yahoo Finance· 2 years agoEliem Therapeutics Inc (NASDAQ: ELYM) has reported results from its Phase 2a trial investigating...
Quite a few insiders invested in e-therapeutics plc (LON:ETX) last year which is positive news for...
Simply Wall St. via Yahoo Finance· 2 years agoIt is usually uneventful when a single insider buys stock. However, When quite a few insiders buy...
e-therapeutics Full Year 2023 Earnings: UK£0.015 loss per share (vs UK£0.017 loss in FY 2022)
Simply Wall St. via Yahoo Finance· 1 year agoe-therapeutics (LON:ETX) Full Year 2023 Results Key Financial Results Net loss: UK£8.27m (loss...
Companies Like e-therapeutics (LON:ETX) Are In A Position To Invest In Growth
Simply Wall St. via Yahoo Finance· 2 years agoWe can readily understand why investors are attracted to unprofitable companies. For example,...
We're Hopeful That e-therapeutics (LON:ETX) Will Use Its Cash Wisely
Simply Wall St. via Yahoo Finance· 5 months agoEven when a business is losing money, it's possible for shareholders to make money if they buy a...
Eliem Pauses Development On Depression Drug, Lays Off 55% Workforce
Benzinga via Yahoo Finance· 1 year agoEliem Therapeutics Inc (NASDAQ: ELYM) announced reprioritizing its pipeline to focus on its high...
Eliem Announces Updated Development Plans For Its Delayed Depression Candidate
Benzinga via Yahoo Finance· 2 years agoIn April, Eliem Therapeutics Inc (NASDAQ: ELYM) delayed ETX-155 into Phase 2a depression trials to...
